4
Changes in Ownership
ImmunityBio, Inc. Filed Acc 0001326110-23-000005
Chief Financial Officer acquired 7,598 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sachs David C. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-31 | Exercise or conversion : show line 1 in the form | +7,598 | 51,298 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-31 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −7,598 | 136,793 | D |
Loading xslF345X03/wf-form4_167288693724683.xml…